Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

Two more women allege harassment by Cambridge professor

Simon Goldhill, accused of ‘slobbery kiss’ on a student, is also claimed to have groped a woman at a meeting of the Society for Classical St...

Footage captures firebombing of Sydney building company CEO’s home

The Sydney Morning Herald

April 24, 2026

Former Chicago Bulls coach Billy Donovan lists Lincoln Park home for $4.5M

Chicago Tribune

April 24, 2026

49ers GM John Lynch is begging for somebody to trade for Brandon Aiyuk

Yardbarker

April 26, 2026

Mercuria to invest in smelters and mines as it expands metals push

Financial Times

April 24, 2026

NVS SMA drug gets CHMP backing, malaria drug wins WHO prequalification

Posted on April 27, 2026
By Bing News
0 Views
1 min read

NVS SMA drug gets CHMP backing, malaria drug wins WHO prequalification

Novartis NVS announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion recommending marketing authorization for Itvisma (intrathecal onasemnogene abeparvovec) for the treatment of individuals aged two years and older, living with 5q spinal muscular atrophy (SMA) caused by survival motor neuron 1 (SMN1) gene mutations. The European Commission’s (EC) final decision...